Critical review of PET, SPECT and neuroreceptor studies in schizophrenia
Hypotheses having to do with the neurochemical basis for mental disease can be tested by noninvasive measurement of flow, metabolism and neuroreceptor concentrations in various parts of the brain. The capabilities of these technologies for accurate absolute quantitation are limited by the instrument resolution and the limited statistics associated with allowable radiation doses. Nevertheless, very important new information regarding the brain function in normal and diseased states can be gleaned from the techniques of positron emission tomography (PET) and single photon emission tomography (SPECT). This chapter presents the critical problems which face the clinical researcher who endeavors to test hypotheses regarding mental illnesses using PET or SPECT. First, the quantitative capabilities of emission tomography will be discussed; then the special requirements of SPECT for attenuation correction will be reviewed. Next, the physiological principles required for inter-institutional comparisons are presented.
KeywordsPositron Emission Tomography Attenuation Correction Single Photon Emission Tomography Positron Emission Tomography System Lawrence Berkeley Laboratory
Unable to display preview. Download preview PDF.
- Budinger TF, Huesman RH (1985) Ten percepts for quantitative data acquisition and analysis. Circulation 72:IV-53—IV-62Google Scholar
- Budinger TF, Derenzo SE, Huesman RH (1984) Instrumentation for positron emission tomography. Ann Neurol 15:§35—§ 43Google Scholar
- Moses WW, Derenzo SE, Budinger TF (1992) Design for a high-rate, high resolution PET module using room-temperature silicon photodiodes for crystal identification. J Nucl Med 33Google Scholar